|
title
|
type of...
|
start
|
status
|
|
| |
|
A Phase 1/2a Dose Escalation and Cohort Exp...
|
clinical studies
|
2016
|
automatically...
|
|
|
A Phase 2, multi-center, open label study o...
|
clinical studies
|
2017
|
ongoing - rec...
|
|
|
A phase I/Ib, open-label, multi-center dose...
|
clinical studies
|
2019
|
ongoing - rec...
|
|
|
A phase Ib multi-center, open label, 2-arm ...
|
clinical studies
|
2011
|
completed
|
|
|
A Phase Ib/II, open-label, multicenter stud...
|
clinical studies
|
2013
|
automatically...
|
|
|
A PHASE II, OPEN-LABEL, MULTICENTER STUDY
|
clinical studies
|
2021
|
scheduled
|
|
|
A phase III, multicenter, randomized, open-...
|
clinical studies
|
2013
|
automatically...
|
|
|
A Randomized, Double-blind, Adaptive, Phase...
|
clinical studies
|
2020
|
ongoing - rec...
|
|
|
A randomized, double-blind, placebo-control...
|
clinical studies
|
2012
|
completed
|
|
|
An open-label Phase 1/2a study of BAL101553...
|
clinical studies
|
2016
|
ongoing - rec...
|
|
|
An open-label, randomized, parallel group s...
|
clinical studies
|
2011
|
completed
|
|
|
Cachexia and Toxicity: cachexia-based dosin...
|
clinical studies
|
2014
|
automatically...
|
|
|
Circulating micro-RNA profiling in patients...
|
fundamental r...
|
2012
|
completed
|
|
|
Clinical activity of tamoxifen in postmenop...
|
clinical studies
|
2011
|
completed
|
|
|
Cytochrom p450 3A4 and 1A2 phenotyping for ...
|
clinical studies
|
2012
|
automatically...
|
|
|
ETOP 2-11 (BELIEF) An open-label phase II t...
|
clinical studies
|
2012
|
ongoing - fol...
|
|
|
First in human clinical development of the ...
|
clinical studies
|
2010
|
aborted
|
|
|
FLOxTox: Assessment of the Polygenic Basis ...
|
clinical studies
|
2009
|
completed
|
|
| |
